Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Oxalyl chloride | HCID 65578 | — |
| Reactant | HCID 178484810 | HCID 178484810 | — |
| Solvent | Formic Acid | HCID 284 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 178497419 | HCID 178497419 | — |
Reaction Steps
To a solution of imidazole (783 mg) and triethylamine (2.41 ml) in chloroform (80 ml) is added dropwise formic acid (709 μl) with stirring under ice-cooling. Oxalyl chloride (1.00 ml) in chloroform (10 ml) is further added thereto, and the mixture is stirred at room temperature for 0.5 hour. The reaction solution is cooled again with ice, and thereto is added trans-5-methoxycarbonyl-3-[4-(methylamino)cyclohexylcarbonylamino]-N-(5-chloropyridine-2-yl)benzofuran-2-carboxamide hydrochloride (1.50 g) obtained in Example 218. The mixture is warmed to room temperature and stirred for 3 hours. To the reaction solution are poured ice-water and a saturated aqueous sodium hydrogen carbonate solution, and the mixture is extracted with chloroform. The extract is washed with a saturated brine, and dried over sodium sulfate. The solvent is evaporated under reduced pressure, and the resulting residue is purified by NH-silica gel column chromatography (eluent: chloroform) to give the title compound (1.45 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07531537B2 |
|---|
| Source dataset | uspto-grants-2009_05 |
|---|
| ORD ID | ord-19160bea9d94499c92397cfe57527252 |
|---|
| Source note | uspto-grants-2009_05 |
|---|